Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Orgenesis Inc., a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. The company also provides development services, including regulatory services, pre-clinical studies, intellectual property services, and GMP process translation, as well as support services; hospital services; cell process development services; and distributed cell processing services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland. more
Time Frame | ORGS | Sector | S&P500 |
---|---|---|---|
1-Week Return | -14.06% | 0.31% | -1.26% |
1-Month Return | 80% | 0.6% | -4.16% |
3-Month Return | -49.53% | -9.44% | -0.46% |
6-Month Return | -76.86% | -5.15% | 3.58% |
1-Year Return | -54.84% | 0.33% | 22.47% |
3-Year Return | -92.99% | 4.53% | 25.13% |
5-Year Return | -96.55% | 35.98% | 77.7% |
10-Year Return | -97.58% | 100.72% | 190.12% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 33.26M | 7.65M | 35.50M | 36.02M | 530.00K | [{"date":"2019-12-31","value":92.31,"profit":true},{"date":"2020-12-31","value":21.24,"profit":true},{"date":"2021-12-31","value":98.55,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":1.47,"profit":true}] |
Cost of Revenue | 18.12M | 30.62M | 28.16M | 20.44M | 6.25M | [{"date":"2019-12-31","value":59.17,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":91.97,"profit":true},{"date":"2022-12-31","value":66.76,"profit":true},{"date":"2023-12-31","value":20.43,"profit":true}] |
Gross Profit | 15.14M | (22.97M) | 7.34M | 15.59M | (5.72M) | [{"date":"2019-12-31","value":97.14,"profit":true},{"date":"2020-12-31","value":-147.36,"profit":false},{"date":"2021-12-31","value":47.11,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-36.73,"profit":false}] |
Gross Margin | 45.53% | (300.13%) | 20.68% | 43.26% | (1080.19%) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-659.26,"profit":false},{"date":"2021-12-31","value":45.43,"profit":true},{"date":"2022-12-31","value":95.03,"profit":true},{"date":"2023-12-31","value":-2372.71,"profit":false}] |
Operating Expenses | 39.74M | 103.43M | 50.02M | 22.95M | 49.17M | [{"date":"2019-12-31","value":38.42,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":48.36,"profit":true},{"date":"2022-12-31","value":22.19,"profit":true},{"date":"2023-12-31","value":47.53,"profit":true}] |
Operating Income | (24.60M) | (95.78M) | (42.68M) | (7.37M) | (53.64M) | [{"date":"2019-12-31","value":-2460400000,"profit":false},{"date":"2020-12-31","value":-9578100000,"profit":false},{"date":"2021-12-31","value":-4268200000,"profit":false},{"date":"2022-12-31","value":-736800000,"profit":false},{"date":"2023-12-31","value":-5363600000,"profit":false}] |
Total Non-Operating Income/Expense | (1.33M) | (1.86M) | 23.44M | (6.42M) | (9.88M) | [{"date":"2019-12-31","value":-5.7,"profit":false},{"date":"2020-12-31","value":-7.92,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-27.38,"profit":false},{"date":"2023-12-31","value":-42.16,"profit":false}] |
Pre-Tax Income | (25.48M) | (96.74M) | (17.95M) | (11.96M) | (64.44M) | [{"date":"2019-12-31","value":-2547800000,"profit":false},{"date":"2020-12-31","value":-9673600000,"profit":false},{"date":"2021-12-31","value":-1795100000,"profit":false},{"date":"2022-12-31","value":-1196000000,"profit":false},{"date":"2023-12-31","value":-6444500000,"profit":false}] |
Income Taxes | 563.00K | (1.61M) | 108.00K | 209.00K | 473.00K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-285.79,"profit":false},{"date":"2021-12-31","value":19.18,"profit":true},{"date":"2022-12-31","value":37.12,"profit":true},{"date":"2023-12-31","value":84.01,"profit":true}] |
Income After Taxes | (26.04M) | (95.13M) | (18.06M) | (12.17M) | (64.92M) | [{"date":"2019-12-31","value":-2604100000,"profit":false},{"date":"2020-12-31","value":-9512700000,"profit":false},{"date":"2021-12-31","value":-1805900000,"profit":false},{"date":"2022-12-31","value":-1216900000,"profit":false},{"date":"2023-12-31","value":-6491800000,"profit":false}] |
Income From Continuous Operations | (26.04M) | (95.13M) | (18.06M) | (12.17M) | (21.85M) | [{"date":"2019-12-31","value":-2604100000,"profit":false},{"date":"2020-12-31","value":-9512700000,"profit":false},{"date":"2021-12-31","value":-1805900000,"profit":false},{"date":"2022-12-31","value":-1216900000,"profit":false},{"date":"2023-12-31","value":-2184700000,"profit":false}] |
Income From Discontinued Operations | (1.63M) | 96.20M | - | - | - | [{"date":"2019-12-31","value":-1.7,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (26.04M) | (95.13M) | (18.06M) | (12.17M) | (55.36M) | [{"date":"2019-12-31","value":-2604100000,"profit":false},{"date":"2020-12-31","value":-9512700000,"profit":false},{"date":"2021-12-31","value":-1805900000,"profit":false},{"date":"2022-12-31","value":-1216900000,"profit":false},{"date":"2023-12-31","value":-5536100000,"profit":false}] |
EPS (Diluted) | (3.56) | (7.59) | (1.67) | (1.07) | - | [{"date":"2019-12-31","value":-356,"profit":false},{"date":"2020-12-31","value":-758.84,"profit":false},{"date":"2021-12-31","value":-167,"profit":false},{"date":"2022-12-31","value":-107,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
ORGS | |
---|---|
Current Ratio | 0.07 |
Quick Ratio | 0.07 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ORGS | |
---|---|
ROA (LTM) | -52.77% |
ROE (LTM) | -727.25% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ORGS | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 1.81 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.80 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ORGS | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 6.67 |
P/B | 1.26 |
Price/FCF | NM |
EV/R | 28.33 |
EV/Ebitda | NM |
PEG | NM |
Orgenesis Inc (ORGS) share price today is $1.51
Yes, Indians can buy shares of Orgenesis Inc (ORGS) on Vested. To buy Orgenesis Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ORGS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Orgenesis Inc (ORGS) via the Vested app. You can start investing in Orgenesis Inc (ORGS) with a minimum investment of $1.
You can invest in shares of Orgenesis Inc (ORGS) via Vested in three simple steps:
The 52-week high price of Orgenesis Inc (ORGS) is $10.8. The 52-week low price of Orgenesis Inc (ORGS) is $0.87.
The price-to-earnings (P/E) ratio of Orgenesis Inc (ORGS) is
The price-to-book (P/B) ratio of Orgenesis Inc (ORGS) is 1.26
The dividend yield of Orgenesis Inc (ORGS) is 0.00%
The market capitalization of Orgenesis Inc (ORGS) is $7.81M
The stock symbol (or ticker) of Orgenesis Inc is ORGS